Cancer BiologybioRxivPreprint
Therapy-Induced Clonal Selection as a Driver of Response to JAK Inhibitors in Myelofibrosis
Sebastiano Rontauroli, Chiara Carretta, Matteo Bertesi…·Rossella Manfredini
This study investigates clonal dynamics in myelofibrosis patients responding to JAK inhibitors, finding that mutation acquisition order and co-mutation status influence treatment sensitivity and disease persistence.
DOI 10.64898/2026.06.20.733514